Studying the Evolving Knowledge of Adverse Drug Reactions in Order to Facilitate the Rational Use of Medicines in Paediatric Patients
Open Access
- 2 April 2019
- journal article
- review article
- Published by MDPI AG in Healthcare
- Vol. 7 (2) , 55
Abstract
Pharmacovigilance, which is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems, generates knowledge to facilitate the rational use of medicines. When a medicine is first marketed, there is limited information on adverse drug reactions (ADRs), especially in paediatrics, where medicines are less likely to have been extensively studied. Knowledge in drug safety is built up over time when more (in number, and more heterogeneous) patients are treated than were studied in the randomised controlled trials preceding the marketing of a medicine. Previously not recognised ADRs are often initially described in case reports and case series. Prospective cohort studies are useful in determining the incidence and risk factors of common ADRs. Case series and pharmacovigilance reporting systems have been useful in identifying previously unknown uncommon ADRs and risk factors for specific ADRs. This brief review provides examples that illustrate how various study designs and data sources contribute to the evolving knowledge of ADRs that is essential to help develop guidelines and improve the rational use of medicines.Keywords
This publication has 34 references indexed in Scilit:
- Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissionsBMC Medicine, 2013
- Number of Patients Studied Prior to Approval of New Medicines: A Database AnalysisPLOS Medicine, 2013
- Adverse drug events in a paediatric intensive care unit: a prospective cohortBMJ Open, 2013
- Adverse drug reaction-related admissions in paediatrics, a prospective single-centre studyBMJ Open, 2012
- Adverse Drug Reactions in Children—A Systematic ReviewPLOS ONE, 2012
- Pharmacovigilance in children in Camagüey Province, CubaEuropean Journal of Clinical Pharmacology, 2012
- Sudden Death and Use of Stimulant Medications in YouthsAmerican Journal of Psychiatry, 2009
- Surveillance for fatal suspected adverse drug reactions in the UKArchives of Disease in Childhood, 2002
- Glucuronidation in HumansClinical Pharmacokinetics, 1999
- ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA A DISEASE ENTITY IN CHILDHOODThe Lancet, 1963